Cresco Labs (CRLBF) Cost of Revenue (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Cost of Revenue came in at $75.9 million in Q1 2026, down 12.91% YoY from $87.1 million in Q1 2025, and down 3.01% on a QoQ basis from $78.2 million in Q4 2025.
Cresco Labs (CRLBF) Cost of Revenue (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Cost of Revenue data on file, last reported at $75.9 million in Q1 2026.
- Quarterly Cost of Revenue fell 12.91% year-over-year to $75.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320.0 million (down 9.83% YoY) and the FY2025 annual result came in at $331.3 million, down 7.95% from the prior year.
- Cost of Revenue retreated to $75.9 million in Q1 2026, from $78.2 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $111.9 million in Q4 2022 to a low of $75.9 million in Q1 2026.
- A 5-year average of $94.8 million and a median of $92.1 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue jumped 48.17% — and 2024, when it dropped 19.43%.
- Tracing CRLBF's Cost of Revenue over 5 years: stood at $111.9 million in 2022, then retreated by 17.68% to $92.1 million in 2023, then declined by 0.23% to $91.9 million in 2024, then fell by 14.86% to $78.2 million in 2025, then declined by 3.01% to $75.9 million in 2026.
- The last three Cost of Revenue figures came in at $75.9 million (Q1 2026), $78.2 million (Q4 2025), and $85.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cresco Labs | 297.58 Mn | 233.46 Mn | 86.95 Mn | 86.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.88 Mn |
| Mar 31, 2026 | 75.88 Mn |
| Dec 31, 2025 | 78.23 Mn |
| Dec 31, 2025 | 78.23 Mn |
| Sep 30, 2025 | 85.55 Mn |
| Sep 30, 2025 | 85.55 Mn |
| Jun 30, 2025 | 80.37 Mn |
| Jun 30, 2025 | 80.37 Mn |
| Mar 31, 2025 | 87.13 Mn |
| Mar 31, 2025 | 87.13 Mn |
| Dec 31, 2024 | 91.88 Mn |
| Dec 31, 2024 | 91.88 Mn |
| Sep 30, 2024 | 86.35 Mn |
| Sep 30, 2024 | 86.35 Mn |
| Jun 30, 2024 | 89.58 Mn |
| Jun 30, 2024 | 89.58 Mn |
| Mar 31, 2024 | 92.08 Mn |
| Mar 31, 2024 | 92.08 Mn |
| Dec 31, 2023 | 92.09 Mn |
| Dec 31, 2023 | 92.09 Mn |